These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21477588)

  • 1. Cytokines and effector T cell subsets causing autoimmune CNS disease.
    Petermann F; Korn T
    FEBS Lett; 2011 Dec; 585(23):3747-57. PubMed ID: 21477588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
    Oh SJ; Chung DH
    J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Permanent effector phenotype of neuroantigen-specific T cells acquired in the central nervous system during experimental allergic encephalomyelitis.
    Hofstetter HH; Toyka KV; Gold R
    Neurosci Lett; 2006 Jan; 391(3):127-30. PubMed ID: 16198481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological basis for the development of tissue inflammation and organ-specific autoimmunity in animal models of multiple sclerosis.
    Korn T; Mitsdoerffer M; Kuchroo VK
    Results Probl Cell Differ; 2010; 51():43-74. PubMed ID: 19513635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
    Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
    J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
    Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
    J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm.
    Batoulis H; Addicks K; Kuerten S
    Ann Anat; 2010 Aug; 192(4):179-93. PubMed ID: 20692821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis.
    Krakowski ML; Owens T
    Eur J Immunol; 1997 Nov; 27(11):2840-7. PubMed ID: 9394808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
    Cohen SJ; Cohen IR; Nussbaum G
    J Immunol; 2010 Jan; 184(1):212-21. PubMed ID: 19949074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune inflammation from the Th17 perspective.
    Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
    Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cytokine and chemokine production characterizes experimental autoimmune meningitis and experimental autoimmune encephalomyelitis.
    Perrin PJ; Rumbley CA; Beswick RL; Lavi E; Phillips SM
    Clin Immunol; 2000 Feb; 94(2):114-24. PubMed ID: 10637096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
    Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
    Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ; Lukacs NW; McRae BL; Strieter RM; Kunkel SL; Miller SD
    J Immunol; 1995 Nov; 155(10):5003-10. PubMed ID: 7594507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting monocyte recruitment in CNS autoimmune disease.
    Izikson L; Klein RS; Luster AD; Weiner HL
    Clin Immunol; 2002 May; 103(2):125-31. PubMed ID: 12027417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation of T cells in experimental autoimmune encephalomyelitis and multiple sclerosis].
    Rodríguez-Rodríguez Y; Suárez-Luis I
    Rev Neurol; 2003 Apr 1-15; 36(7):649-52. PubMed ID: 12666047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
    Jadidi-Niaragh F; Mirshafiey A
    Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.